Lakefront Biotherapeutics | GLPG - Ebit





Ebit تغيير تاريخ
argenx SE USD 493M 99M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
Biogen USD -243.8M 758.1M 2026-06
Genmab DKK 407M 221M 2026-06
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
GRIFOLS EUR 428M 179M 2026-06
Hikma Pharmaceutical USD 348M 31M 2025-12
Incyte USD 700.4M 356.23M 2026-06
Merck EUR 1.1B 51M 2026-06
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
Novartis USD 4.73B 549M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 1.12B 811M 2026-06
UCB EUR 1.29B 571M 2025-12
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06